Diabetes News

  • Expanded TIMI risk score deemed practical in diabetes
    (HealthDay)—The TIMI (Thrombolysis in Myocardial Infarction) Risk Score for Secondary Prevention (TRS 2°P) is an accurate predictor of atherothrombotic disease among patients with type 2 diabetes, according to a study published online Dec. 1 in Diabetes Care. Read more »
  • Prevalence of diabetes tops 20 percent among U.S. veterans
    (HealthDay)—The overall prevalence of diabetes among U.S. veterans was 20.5 percent in 2013 to 2014, according to a study published online Dec. 14 in the U.S. Centers for Disease Control and Prevention's Preventing Chronic Disease. Read more »
  • Stricter short-term glycemic control may increase remission
    (HealthDay)—Stricter glycemic control during short-term intensive insulin therapy for newly diagnosed type 2 diabetes patients is associated with a higher likelihood of remission at one year, according to a study published online Nov. 30 in the Journal of Diabetes Investigation. Read more »
  • High success rate reported for diabetic Charcot foot surgery
    Nearly four out of five diabetic patients with severe cases of a disabling condition called Charcot foot were able to walk normally again following surgery, a Loyola Medicine study has found. Read more »
  • Measuring quality of life important with diabetes Tx
    (HealthDay)—Patients with diabetes report worse quality of life (QoL) with more intensified treatment, according to a study published in online Nov. 28 in Diabetes Care. Read more »
  • Immunotherapy, gene editing advances extend to Type 1 Diabetes
    Advances in engineering T cells to treat cancer are paving the way for new immunotherapies targeted at autoimmune diseases, including type 1 diabetes. Now, researchers are also investigating therapies that reprogram T cells to "turn down" an immune response, which may hold promise for curing type 1 diabetes, as well as a number of diseases where overactive T cells attack a person's healthy cells and organs. Read more »
  • New findings show what develops in body cells during type 2 diabetes onset
    Researchers at Dublin City University and their project partners in the EU FP7 funded DEXLIFE project have found fresh evidence to explain the processes that occur in the body's cells leading to the onset of type2 diabetes. Read more »
  • Younger newly-diagnosed patients with type 2 diabetes are hit hard by the disease
    The common view of type 2 diabetes as an old person's disease is becoming seriously outdated in step with the increasing number of persons under the age of 45 who develop the disease. New research from Aarhus University now shows that younger persons newly-diagnosed with type 2 diabetes have significantly poorer health and thus a high risk of delayed complications compared with type 2 diabetes patients who first contract the disease twenty years later in life. Read more »
  • 'Death receptors'—New markers for type 2 diabetes and cardiovascular disease
    Researchers at Lund University in Sweden have found that the presence of death receptors in the blood can be used to directly measure the risk of developing cardiovascular diseases and type 2 diabetes. "We see that people with known risk factors such as high blood sugar and high blood fats also have heightened death receptor levels," says Professor Jan Nilsson who led the study. Read more »
  • Scientists develop new approaches diabetes treatment
    A team of scientists from the Ural Federal University (UrFU) and the Institute of Immunology and Physiology modeled type 1 diabetes in an experiment to study recovery processes in the pancreas. The results of the study will contribute to new approaches to treating diabetes. The researchers have published an article in Biomedicine & Pharmacotherapy. Read more »
  • Personalized blood sugar goals can save diabetes patients thousands
    A cost analysis by researchers at the University of Chicago Medicine shows treatment plans that set individualized blood sugar goals for diabetes patients, tailored to their age and health history, can save $13,546 in health care costs over their average lifetime when compared with treatment strategies that stick to a uniform national standard. Read more »
  • Beta-cell sensitivity to glucose impaired after gastric bypass
    (HealthDay)—Individuals with prior Roux-en-Y gastric bypass (GB) have blunted β-cell sensitivity to changes in glycemia, according to a study published online Nov. 20 in Diabetes, Obesity and Metabolism. Read more »
  • Kidney disease increases risk of diabetes, study shows
    Diabetes is known to increase a person's risk of kidney disease. Now, a new study from Washington University School of Medicine in St. Louis suggests that the converse also is true: Kidney dysfunction increases the risk of diabetes. Read more »
  • Bariatric surgery alters liver fatty acid metabolism
    (HealthDay)—Bariatric surgery seems to change fatty acid metabolism in the liver, according to a study published online Nov. 20 in Diabetes Care. Read more »
  • Losing weight is hard, but not any harder if you have type 2 diabetes
    A study has found weight loss could reverse type 2 diabetes. The UK clinical trial showed that 46% of people who followed a low-calorie diet, among other measures, for 12 months were able to stop their type 2 diabetes medications. Read more »
  • Moving more may match focused exercise in prediabetes
    (HealthDay)—The accumulation of total physical activity (PA) over the day may be as important as achieving the intensity of moderate-to-vigorous PA (MVPA) for improved cardiometabolic health of adults with prediabetes, according to a study published online Nov. 20 in Diabetes Care. Read more »
  • Program aids quality of life for older adults with T2DM
    (HealthDay)—A community-based program improves quality of life and self-management in older adults with type 2 diabetes mellitus (T2DM) and comorbidities, according to a study published online Nov. 27 in the Journal of the American Geriatrics Society. Read more »
  • FDA approves ozempic for type 2 diabetes
    (HealthDay)—A new once-weekly diabetes medication that lowers blood glucose and also helps patients lose weight has been approved by the U.S. Food and Drug Administration. Read more »
  • Ozempic approved for type 2 diabetes
    (HealthDay)—Ozempic (semaglutide) has been approved by the U.S. Food and Drug Administration as a weekly injection to treat type 2 diabetes in adults. Read more »
  • Link between diabetes, antibiotic use called into question
    (HealthDay)—Previous findings that systemic use of antibiotics increases the risk of diabetes may actually be explained by clinical and lifestyle factors, according to a study published online Nov. 20 in Diabetes, Obesity and Metabolism. Read more »
Pin It